Apollo Hospitals Enterprise Share Price

NSE
6999.5
+3.00 (0.04%)
APOLLOHOSP • 13 Jun, 2025 | 03:29 PM
BUY

1Y Annualised Return

12.73%

3Y Annualised Return

23.61%

5Y Annualised Return

37.80%

The current prices are delayed, login or Open Demat Account for live prices.

Apollo Hospitals Enterprise SIP Return Calculator

Over the past

1 year
3 years
5 years

Total Investment of ₹65,00,000

Would have become ₹69,33,440 (+6.67%)

Daily SIP of 25,000 would have become 69,33,440 in 1 year with a gain of 4,33,440 (+6.67%)

Apollo Hospitals Enterprise Stock Performance
Today’s Low - High
6,923.00
7,037.50
6,923.00
7,037.50
52 Week Low - High
6,001.00
7,545.35
6,001.00
7,545.35

Open

6,979.00

Prev. Close

6,996.50

Total Traded Value

257.24 Cr

View details of Market Depth
Apollo Hospitals Enterprise Fundamental

Market Cap (in crs)

1,00,570.18

Face Value

5

Turnover (in lacs)

25,724.02

Key Metrics
Qtr Change %
14.6
Dividend yield 1yr %
Below industry Median
0.3

Apollo Hospitals Enterprise Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Apollo Hospitals Enterprise Quarterly Revenue

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
5592.2 Cr
5526.9 Cr
5589.3 Cr
5085.6 Cr
4943.9 Cr

Apollo Hospitals Enterprise Yearly Revenue

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
21994.3 Cr
19165.5 Cr
16702.8 Cr
14740.8 Cr
10605 Cr
11273.7 Cr

Apollo Hospitals Enterprise Quarterly Net Profit/Loss

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
404 Cr
374.1 Cr
390 Cr
304 Cr
249.8 Cr

Apollo Hospitals Enterprise Yearly Net Profit/Loss

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
1472.1 Cr
917 Cr
887.5 Cr
1101.1 Cr
136 Cr
434.8 Cr
Apollo Hospitals Enterprise Result Highlights
  • Apollo Hospitals Enterprise Ltd reported a 11.1% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 15.1%.

  • Its expenses for the quarter were down by 8.8% QoQ and up 13.4% YoY.

  • The net profit decreased 31.9% QoQ and increased 77.4% YoY.

  • The earnings per share (EPS) of Apollo Hospitals Enterprise Ltd stood at 17.6 during Q4FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Apollo Hospitals Enterprise shareholding Pattern

Promoter
29.3%
Foreign Institutions
42.7%
Mutual Funds
15.4%
Domestic Institutions
22.6%
Public
5.4%
Promoter
29.3%
Foreign Institutions
45.3%
Mutual Funds
12.8%
Domestic Institutions
20.2%
Public
5.2%
Promoter
29.3%
Foreign Institutions
45.4%
Mutual Funds
12.8%
Domestic Institutions
20.1%
Public
5.1%
Promoter
29.3%
Foreign Institutions
43.9%
Mutual Funds
14.7%
Domestic Institutions
21.4%
Public
5.4%
Promoter
29.3%
Foreign Institutions
45.6%
Mutual Funds
14.3%
Domestic Institutions
19.8%
Public
5.3%
Promoter
29.3%
Foreign Institutions
46.2%
Mutual Funds
13.9%
Domestic Institutions
19.2%
Public
5.3%

Apollo Hospitals Enterprise Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
6999.5
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
6,961.10
10Day EMA
6,945.30
12Day EMA
6,943.80
20Day EMA
6,940.60
26Day EMA
6,933.70
50Day EMA
6,886.20
100Day EMA
6,833.40
200Day EMA
6,736.10
5Day SMA
6,953.80
10Day SMA
6,917.00
20Day SMA
6,949.50
30Day SMA
6,945.90
50Day SMA
6,932.40
100Day SMA
6,716.20
150Day SMA
6,850.40
200Day SMA
6,882.40
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
232435 Rs
371415 Rs
Week Rs
306444 Rs
454870 Rs
Month Rs
294042 Rs
461146 Rs
Resistance & Support
6,985.00
Pivot
Resistance
First Resistance
7,047
Second Resistance
7,099.50
Third Resistance
7,161.50
Support
First Support
6,932.50
Second support
6,870.50
Third Support
6,818
Relative Strength Index
54.94
Money Flow Index
47.25
MACD
10.07
MACD Signal
8.40
Average True Range
121.94
Average Directional Index
8.86
Rate of Change (21)
-1.10
Rate of Change (125)
-4.72
Shareholding
Name
Holding Percent
HDFC TRUSTEE COMPANY LIMITED
2.38
MIRAE ASSET ELSS TAX SAVER FUND
1.88
SBI NIFTY 50 ETF
1.41
AXIS MUTUAL FUND TRUSTEE LIMITED
1.23
FRANKLIN INDIA FLEXI CAP FUND
1.06
NIPPON LIFE INDIA TRUSTEE LTD
1.04
GOVERNMENT OF SINGAPORE
1.76
SCHRODER INTERNATIONAL SELECTION FUND ASIAN OPPORTUNITIES
1.17
GOVERNMENT PENSION FUND GLOBAL
1.13
KOTAK FUNDS - INDIA MIDCAP FUND
1.07
LIFE INSURANCE CORPORATION OF INDIA
3.77

Apollo Hospitals Enterprise Latest News

13 JUN 2025 | Friday

Buy, Sell, Or Hold: Aditya Agarwala Recommends Apollo Hospitals, Tech Mahindra

11 JUN 2025 | Wednesday

L&T's Buildings & Factories proposes to enter into 2,400 crore contract with Apollo Hospitals

10 JUN 2025 | Tuesday

Apollo Hospitals Enterprise Ltd - 508869 - Announcement under Regulation 30 (LODR)-Acquisition

View More

Apollo Hospitals Enterprise Company background

Founded in: 1979
Managing director: Suneeta Reddy

Founded in: 1979 Managing director: Suneeta Reddy

Apollo Hospitals Enterprise Limited (AHEL) is a very well-known name in private healthcare in Asia. They're renowned for setting high standards in healthcare. But hospitals are not all they do. Apollo also has their hands in pharmacies, primary care clinics, and diagnostic services.

Apollo's adventure started on December 5, 1979. That’s when they opened their very first 250-bed hospital in Chennai, India. The goal? To provide specialty and super-specialty medical services like Indians had never seen before. 1985, and they were already expanding with 46 more beds, actually establishing themselves as a major player in the healthcare game.

Through the years, Apollo Hospitals has been sort of a pioneer in transforming the Indian healthcare scene. One of their big moves was introducing corporate healthcare delivery. Now why’s that important? It helped make high-quality healthcare more accessible and affordable for a lot more folks.

Expanding Facilities and Innovations in Healthcare

Back in 1986, Apollo Hospitals launched the Apollo Health Association (AHA) to introduce some fresh health insurance options. Do note that this was actually a game-changer—it gave people access to world-class healthcare across 76 top hospitals in select cities, making high-quality medical care more affordable.

In the late 80s, and Apollo was leading the charge in healthcare tech. In 1989, they were the first to bring Magnetic Resonance Imaging (MRI) to India, revolutionizing medical diagnostics. They didn’t stop there; they also rolled out some cutting-edge tech like the SOMATOMCR CT scanner, breast-scanning tools, and video endoscopy, which helped catch serious conditions like carcinoma early.

Same year Apollo teamed up with the USSR's I.R.T.C. of Eye Microsurgery to open the Apollo Fyodorov Eye Research Institute. They dived into advanced research and treatments in eye care. But, there's more! In 1991, they launched the Apollo School of Nursing to offer nurses top-tier training and set them up for successful careers.

Expansion and Internationalization

Apollo Hospitals didn't just grow quietly; they kept adding new departments focusing on specialized health services. Back in 1993, they opened a cancer hospital with 150 beds, putting a big emphasis on cutting-edge care and research. It was a big step forward for them.

Then, in 1995, and they opened another cancer hospital, this time in Hyderabad. That was a really big deal for them and a key moment in their growth story.

By the time 1998 rolled around, Apollo Hospitals decided to take a bold step onto the international stage. They teamed up with the Sri Lankan government and opened a super-specialty hospital in Colombo. Do note that this move marked the beginning of Apollo’s adventure into the world market.

Strategic Partnerships

Teaming up with others has been key to Apollo's success. 1997 they joined forces with Jardine, a company from the UK, to bring Health Maintenance Organizations (HMOs) to India. This move was all about matching up with international healthcare standards.

Then, in 2001, Apollo struck another important partnership, this time with the government of Mauritius. This collaboration helped them become a top healthcare provider for the people there. Through these partnerships, Apollo Hospitals have been able to keep up with the latest in healthcare innovations and spread their wings globally.

Technology Integration and Innovations

In 2004, Apollo Hospitals took a big step by teaming up with the Defence Research and Development Organisation (DRDO). They combined their strengths to boost the hospital’s technology. This partnership brought about some cutting-edge medical services, like the Apollo National Heart Plan, which is a full health program that focuses on everything from prevention to disease management and treatment.

By 2005, Apollo had significantly upgraded its technological setup. Did you know that their hospital in Delhi earned the prestigious Joint Commission International (JCI) certification? Note that it is a big deal because it recognizes excellence in quality care and safety.

Diversification into Health Insurance and New Ventures

As part of upping its game, Apollo Hospitals jumped into the health insurance market. In 2006, they joined forces with Deutsche Krankenversicherung AG (DKV) so as to form a joint venture focused on health insurance. Do note that this move was all about boosting their healthcare services and offering a more complete package for patient care.

Then Apollo went big on research too. In 2009, they opened a clinical trial facility in Hyderabad, joining hands with Quintiles Mauritius Holdings Inc. so as to conduct Phase I clinical trials. This was a major step forward in showing their dedication to medical research and innovation.

Plus, they poured resources into new facilities like the Apollo Health City in Hyderabad. This enormous 33-acre site offers all sorts of integrated healthcare services, from prevention and management to wellness and research.

Growth in the Retail Pharmacy Sector

Apollo Hospitals Enterprise has made great progress in the retail pharmacy industry. In 2014, they expanded their market presence by acquiring 320 pharmacy stores from Hetero Med Solutions Limited. This expansion was a big step, increasing their reach in regions like Telangana, Andhra Pradesh, and Tamil Nadu. This strategic move allowed Apollo to improve their operational efficiency and achieve economies of scale, leading to increased profitability and a wider market reach.

2022, and Apollo made another smart move by transferring its pharmacy distribution and the Apollo 24/7 digital healthcare platform to Apollo HealthCo Limited, a wholly-owned subsidiary. This transaction, worth Rs 12,100 million, aligns with Apollo's strategy to concentrate on core healthcare services while giving them a strong foothold in the booming digital healthcare market.

International Expansion and Global Partnerships

Apollo Hospitals Enterprise has been making big moves to go global. One of their standout projects was joining forces with the Hainan Ecological Smart City Group (HESCG) in China so as to set up a cutting-edge hospital in Hainan Province. This partnership is all about bringing Apollo’s expertise in hospital management and medical services to China's booming healthcare scene.

Apollo is keen to connect with international financial bodies and healthcare partners. For example, in December 2016, they landed a huge equity investment of Rs 450 crore from the International Finance Corporation (IFC). This deal gave IFC a 29.03% stake in Apollo Health and Lifestyle Limited (AHLL), a company fully owned by Apollo. This investment was a game-changer, helping AHLL spread its wings and grow its retail healthcare services, which include primary health clinics, day surgery centers, and birthing centers.

Financial Performance and Strategic Investments

Apollo Hospitals has been doing well financially over the years, thanks to its expanding network of hospitals, retail pharmacies, and healthcare services. The Apollo Hospitals Enterprise share price has mirrored this success. In a notable financial move in 2021, Apollo Hospitals raised a significant amount of money through a Qualified Institutional Placement (QIP). By issuing 4.66 million shares at Rs 2511 each, they pulled in about Rs 1,170 crore.

In addition to raising capital, Apollo has fine-tuned its finances by selling off non-core assets. Back in 2016, for instance, they sold their 23.3% stake in Apollo Munich Health Insurance to Munich Re for Rs 163.5 crore. By shedding these non-central assets, Apollo has been able to concentrate more on their primary healthcare services while extracting value from peripheral parts of the business. Their strategy of focusing on core healthcare operations while smartly managing acquisitions, expansions, and divestments keeps them poised for long-term success.

As of 13 Jun, 2025, APOLLOHOSP share price is ₹6994.5. The stock opened at ₹6979 and had closed at ₹6996.5 the previous day. During today’s trading session, APOLLOHOSP share price moved between ₹6,923.00 and ₹7,037.50, with an average price for the day of ₹6.50. Over the last 52 weeks, the stock has recorded a low of ₹6,001.00 and a high of ₹7,545.35. In terms of performance, APOLLOHOSP share price has declined by 3.6% over the past six months and has increased by 12.73% over the last year.

Read More

Apollo Hospitals Enterprise FAQs

Apollo Hospitals Enterprise share price is ₹6999.5 in NSE and ₹6978.75 in BSE as on 13/6/2025.

Apollo Hospitals Enterprise share price in the past 1-year return was 12.7. The Apollo Hospitals Enterprise share hit a 1-year low of Rs. 6001 and a 1-year high of Rs. 7545.35.

The market cap of Apollo Hospitals Enterprise is Rs. 100570.18 Cr. as of 13/6/2025.

The PE ratios of Apollo Hospitals Enterprise is 77.56 as of 13/6/2025.

The PB ratios of Apollo Hospitals Enterprise is 11.51 as of 13/6/2025

The Mutual Fund Shareholding in Apollo Hospitals Enterprise was 15.42% at the end of 13/6/2025.

You can easily buy Apollo Hospitals Enterprise shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Apollo Hospitals Enterprise stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -